Zuzanna Rabczak

Zuzanna Rabczak

Auto-generated profile, based on publicly available information

Zuzanna Rabczak

Faculty of Dentistry, Medical University of Lublin, Lublin, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MKMałgorzata Kuczek
Małgorzata Kuczek
AWAleksandra Wiśniewska
Aleksandra Wiśniewska
KKKarolina Kasprzak
Karolina Kasprzak
ZRZuzanna Rabczak
Zuzanna Rabczak
JMJulia Marek
Julia Marek
NKNatalia Kaleta
Natalia Kaleta
Xenoestrogens constitute a group of endocrine-disrupting chemicals that, by mimicking or interfering with the actions of endogenous estrogens, can affect hormonal balance and reproductive function. Due to their widespread presence in the environment—including plastics, cosmetics, food, and everyday consumer products—complete avoidance of exposure is virtually impossible. However, studies indicate that proper education, lifestyle modifications, and dietary interventions can significantly reduce exposure to these compounds and the associated health risks. This article investigates various strategies for the prevention of xenoestrogen and other endocrine disruptors exposure, the reduction of existing body burdens of these chemicals. The effectiveness of dietary and behavioral interventions is discussed, such as avoiding canned foods and plastic products, as well as using personal care products free from phthalates, parabens, triclosan, and benzophenone-3, all of which have been shown to markedly decrease urinary levels of xenoestrogens and other endocrine disruptors. Therapeutic interventions are also presented, including the use of selected supplements and pharmacological agents such as Chlorella pyrenoidosa, cholestyramine, olestra, coenzyme Q10, melatonin, and multi-strain probiotics, which have demonstrated beneficial effects in reducing the concentrations of endocrine-active compounds and mitigating their toxic effects. These findings underscore the critical role of multifaceted approaches, combining preventative behavioral changes with targeted substance interventions, to effectively mitigate exposure and safeguard public health from ubiquitous endocrine-disrupting chemicals (EDCs).

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JMJulia Marek
Julia Marek
AWAleksandra Wiśniewska
Aleksandra Wiśniewska
KKKarolina Kasprzak
Karolina Kasprzak
MKMałgorzata Kuczek
Małgorzata Kuczek
ZRZuzanna Rabczak
Zuzanna Rabczak
JTJustyna Tasior
Justyna Tasior
Introduction: Psoriatic arthritis (PsA) is a chronic, heterogeneous immune-mediated inflammatory disease affecting multiple clinical domains, including peripheral arthritis, skin lesions, enthesitis, and dactylitis. Given the key role of the IL-23/IL-17 axis in PsA pathogenesis, IL-23 inhibitors have emerged as an important therapeutic option. Methodology: A structured literature search of the PubMed database was performed to identify studies evaluating the efficacy and safety of IL-23 inhibitors in PsA. The available evidence was based mainly on randomized trials of guselkumab, risankizumab, and tildrakizumab. Phase III randomized controlled trials were prioritized, while relevant meta-analyses, network meta-analyses, systematic reviews, and selected post hoc or pooled analyses were included to complement the assessment of multidomain outcomes, structural progression, and safety. Results: IL-23 inhibitors showed significant efficacy in peripheral arthritis and provided clinically meaningful benefits in other important disease domains, including skin lesions, physical function, minimal disease activity, enthesitis, and dactylitis. The most robust evidence supported guselkumab and risankizumab, whereas the evidence base for tildrakizumab remained more limited. Guselkumab also showed the clearest evidence for inhibition of structural progression. Across studies, IL-23 inhibitors demonstrated a generally favorable and stable safety profile, with infections being the most commonly reported adverse events and no clear emerging long-term safety concerns. Conclusions: IL-23 inhibitors represent an effective and clinically relevant therapeutic strategy in PsA, with benefits across multiple disease domains and a generally favorable safety profile. Current evidence most strongly supports guselkumab and risankizumab, while further data are needed to better define the role of tildrakizumab.

5 August 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MNMarcin Narloch
Marcin Narloch
MKMarcelina Kurek
Marcelina Kurek
WSWeronika Skrzypek
Weronika Skrzypek
SSSzymon Skrzypek
Szymon Skrzypek
NDNatalia Domańska
Natalia Domańska
ZRZuzanna Rabczak
Zuzanna Rabczak
Acute Disseminated Encephalomyelitis (ADEM) is an acute, immune-mediated demyelinating disorder of the central nervous system, primarily affecting children between 3 and 7 years of age. It typically occurs 1–3 weeks after a viral, bacterial, or post-vaccination infection. Clinically, it presents with multifocal neurological deficits and encephalopathy, which may include altered consciousness, seizures, or cognitive disturbances. MRI shows widespread demyelinating lesions, mainly in the subcortical white matter. Laboratory findings may include elevated CRP, ESR, leukocytosis, and CSF pleocytosis. Treatment involves high-dose intravenous corticosteroids, with intravenous immunoglobulin or plasma exchange used in severe or refractory cases. Though usually monophasic, up to 25% of patients may experience relapses. Some children may require ICU care and early rehabilitation to address cognitive, motor, or speech deficits, highlighting the importance of timely diagnosis and management.

28 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ZRZuzanna Rabczak
Zuzanna Rabczak
KPKarolina Piatikow
Karolina Piatikow
JRJakub Rusek
Jakub Rusek
PPPatrycja PęKala
Patrycja PęKala
GOGabriela Opolska
Gabriela Opolska
KRKatarzyna Rusek
Katarzyna Rusek
Introduction: The Human Microbiome Project (HMP) has advanced our understanding of the microbiome's role in health and disease. The oral cavity hosts a complex microbiome, comprising over 750 microbial species, including bacteria, archaea, viruses, and fungi. Bacteria, forming dental plaque biofilm, are the primary cause of caries and periodontal diseases. Factors such as oral hygiene and diet influence oral health, with handedness potentially affecting plaque removal efficiency. Methodology: This review, sourced from PubMed, Scopus, and Google Scholar, analyzes hand lateralization’s impact on dental plaque removal and neuroplastic changes linked to motor skill acquisition, using fMRI and mirror neuron studies. Keywords: oral hygiene, handedness, dental plaque, motor skills, oral microbiome. Discussion: Handedness subtly influences dental plaque removal, with right-handers showing better upper left quadrant cleaning and left-handers favoring right quadrants. However, standardized training minimizes these differences, emphasizing technique and education over hand dominance. Conclusions: Handedness has a minor impact on dental plaque removal, with quadrant-specific differences due to accessibility and brushing dynamics. Proper instruction reduces these disparities, emphasizing technique, dexterity, and motivation. Neural plasticity supports non-dominant hand improvement. Future research should explore motor learning and behavioral factors to optimize oral hygiene.

29 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MSMichał Szalach
Michał Szalach
MJMateusz Jasiński
Mateusz Jasiński
ZRZuzanna Rabczak
Zuzanna Rabczak
MNMarcin Narloch
Marcin Narloch
KMKamila Mozga
Kamila Mozga
JWJustyna Wyroślak-Najs
Justyna Wyroślak-Najs
Bezoar is a mass of swallowed foreign material most often composed of hair or fiber. Commonly, bezoars occur in young women with a history of psychiatric disorders, especially trichotillomania and trichophagia. Diagnostically, gastroscopy remains the gold standard. Prevalence is low, affecting up to 0.4% of the general population. Bezoars can lead to ulcer formation and hemorrhagic complications. Literature describes various treatment options, including endoscopic, laparoscopic and open surgical approaches. Psychiatric consultation and follow up are crucial for recurrence prevention. A 73-year old woman with a history of gastric ulcers and depression was urgently admitted to general surgery ward due to fatigue, abdominal pain and a suspicion of gastrointestinal hemorrhage. Outpatient gastroscopy revealed extensive ulceration of the posterior wall of the stomach, a large bezoar and pyloric stenosis. On admission, patient was severely anemic. Endoscopic haemostasis proved unfeasible due to the large bezoar. After initial stabilization, operative treatment was recommended. Laparotomy was performed revealing thickening on the posterior wall of the stomach, stenosis of the duodenum and a large diverticulum on the anterior wall of the descending part of the duodenum. Subtotal gastrectomy and diverticulum resection was performed. Restoration of gastrointestinal continuity was carried out using the Roux-en-Y method. Examination of the specimen confirmed the presence of a four centimeter bezoar and a three centimeter gastric ulcer. Post-surgery period was complicated by pneumonia and peripheral pulmonary embolism. Patient was discharged after treatment in good general and local condition after fifteen days since admission. Despite being rare, bezoars occur and should be taken into consideration during differential diagnosis of gastric symptoms and dyspepsia, even in the elderly population, especially with a history of psychiatric disorders. Bezoars can prevent endoscopic treatment of gastric hemorrhage and force surgeons to perform extensive surgical resections.

30 October 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ZRZuzanna Rabczak
Zuzanna Rabczak
KKKarolina Kasprzak
Karolina Kasprzak
MKMałgorzata Kuczek
Małgorzata Kuczek
AWAleksandra Wiśniewska
Aleksandra Wiśniewska
JMJulia Marek
Julia Marek
MNMarcin Narloch
Marcin Narloch
Introduction: Osteoporosis, a common metabolic bone disease affecting over 200 million people globally, causes decreased bone mass and structural deterioration, increasing fracture risk and reducing quality of life. Dental implants have become a standard treatment for tooth loss, providing functional and aesthetic restoration. However, in osteoporotic patients, compromised bone quality may challenge osseointegration and long-term implant stability, requiring careful assessment and individualized planning. Methodology: A literature review of PubMed, Scopus, and Google Scholar identified recent systematic reviews and meta-analyses on dental implant outcomes in osteoporotic patients, focusing on implant survival, bone loss, and antiresorptive therapy, with studies ≥1-year follow-up included. Results: Most studies show no significant difference in implant survival between osteoporotic and healthy patients, with rates typically above 90%. Slight but significant marginal bone loss was noted, though clinically minor. Bone density and osseointegration were generally comparable, particularly with individualized care and antiresorptive therapy. Osteonecrosis of the jaw was rare and mainly associated with bisphosphonate use. Age, systemic treatment, and local bone conditions influenced outcomes. Factors including patient age, systemic therapy, and local bone conditions influenced implant outcomes. Conclusion: Dental implants in osteoporotic patients demonstrate high survival and predictable outcomes. Minor bone loss is manageable with monitoring and preventive care. Although antiresorptive therapy may increase osteonecrosis risk, interdisciplinary management minimizes complications. Osteoporosis should not be viewed as a contraindication for implant therapy, though further research is needed to refine treatment protocols.